Enanta Pharma (ENTA) Tops Q1 EPS by 17c

Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($1.39), $0.17 better than the analyst estimate of ($1.56). Revenue for the quarter came in at $23.6 million versus the consensus estimate of $21.85 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Pfizer reaffirms 2026 guidance after CFO transition news
• Hyperscale Data launches $300M at-the-market stock offering